Royalty Pharma plc (LS:A2P62D) IPO

Royalty Pharma plc

IPO

Priced at US$28.00 a share on Jun 15, 2020.

Price
US$28.00 a share
Shares offered
77,681,670 Class A ordinary shares · 60,000,000 from the company and 17,681,670 from selling shareholders
Offering size
US$2.18 billion
Underwriters' option
Up to 11,652,250 more shares
Underwriters
J.P. Morgan, Morgan Stanley, BofA Securities, Goldman Sachs & Co. LLC, Citigroup, UBS Investment Bank, Evercore ISI, Cowen, SunTrust Robinson Humphrey, BBVA, DNB Markets, Scotiabank, TD Securities, Academy Securities, AmeriVet Securities, Blaylock Van, LLC, Cabrera Capital Markets, LLC, R. Seelaus & Co. LLC, Ramirez & Co., Inc., Siebert Williams Shank, Tigress Financial Partners · In the order on the cover
Shares delivered
On or about Jun 18, 2020

Steps

StepWhen
Draft sent to the SEC in confidenceFeb 13, 2020
Filed publiclyMay 22, 2020
Amended 3 timesNewest Jun 11, 2020
Shares registered with an exchangeJun 15, 2020
Declared effective by the SECJun 15, 2020
Final prospectus, with the priceJun 17, 2020

From the cover of the final prospectus (424B4) filed Jun 17, 2020